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little. Within the subgroup of inconsistent pain, the pain during
activities and physical function improves. Therefore, identifying different
phenotypes in early symptomatic OA may help to better understand the
progression in OA.
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Purpose: Knee OA-related pain changes over time, but speciﬁc pain
patterns in relation to stage of radiographic disease is not known. It
is hypothesized that at the earliest stage of disease, persons experience
intermittent activity-related pain, while at later stages of disease the pain
becomes more constant, eventually becoming constant with episodes of
intermittent unpredictable pain. A new pain assessment tool for knee
OA, the Intermittent and Constant OA Pain (ICOAP) instrument was
developed to capture these pain patterns, but has not been tested for
this hypothesized correlation with OA duration or severity. To address
this knowledge gap, we evaluated the relationship of ICOAP-deﬁned
progressive pain patterns with radiographically-deﬁned OA duration and
severity.
Methods: The Multicenter Osteoarthritis (MOST) Study is a NIH-funded
cohort study of persons with or at high risk of knee OA. Participants
underwent bilateral knee radiography at baseline, 30, and 60 months,
which were read for OA severity according to Kellgren and Lawrence (KL)
grade. Radiographic knee OA (ROA) was deﬁned as KL ≥2. OA duration
was deﬁned according to clinic visit at which ROA was ﬁrst noted.
At the 60-month visit, knee-speciﬁc ICOAP scores were ascertained,
which assesses presence and severity of intermittent and constant
pain, and for intermittent pain, its frequency (5-point Likert scale
for each). Using the knee-speciﬁc ICOAP, pain stages were deﬁned
from early to late OA as: (1) no pain; (2) at least mild intermittent
pain occurring at least sometimes; (3) at least mild constant pain;
and (4) a combination of the latter two categories. We evaluated the
relationship between ROA duration and severity, respectively, and ICOAP
pain pattern using proportional odds logistic regression with generalized
estimating equations. We also assessed the relation of OA duration and
severity to presence of constant or constant plus intermittent pain vs.
intermittent pain alone.
Results: We studied 2112 participants (3963 knees) at the 60-month
exam who had at least one native knee (mean age 67.7±7.9, mean
BMI 30.6±6.0, 60% female). The majority of knees (63%) had no pain,
30% had intermittent pain (as deﬁned above), 3% had constant pain (as
deﬁned above), and 4% had both. 60% of knees had no ROA, 5.5% had
incident ROA at the 60-mo visit (i.e., shortest duration of OA), 5.5% had
incident ROA at the 30-mo visit, and 29.5% had ROA at the baseline visit
(i.e., longest duration of ROA). Those with longer disease and greater
radiographic severity were more likely to have the pain patterns thought
to be associated with such a disease status (i.e., both intermittent and
constant pain at the “highest” end of the ICOAP pain pattern) (Table).
This relationship for OA duration persisted when limited to only those
with ROA at any time point (Table). For constant pain vs. intermittent
only pain, there was no association for those with the shortest duration
of OA (OR 0.7, 95% CI 0.4–1.3), while those with longer durations of
OA were more likely to have constant instead of intermittent pain (ORs
(95% CI) 1.5 (0.9–2.5) for incident ROA at 30-mo; 1.4 (1.0–2.0) for longest
duration of ROA).
Conclusions: Longer duration and greater severity of ROA are associated
with greater likelihood of constant plus intermittent pain. These
ﬁndings support the prior qualitative data suggesting a progression from
intermittent to constant pain punctuated by intermittent unpredictable
pain with worsening knee OA over time. Further reﬁnement of discerning
at what stage of OA pain patterns change from being intermittent in
nature to constant and then to constant with unpredictable intermittent
pain will require further longitudinal data in which greater variety in
duration (and severity of OA) is captured along with the unpredictability
of the intermittent pain.
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Purpose: Costs related to the ﬁnal answer of progressive knee
osteoarthritis (OA), total knee replacement (TKR) surgery, are tremendous
and will increase further due to increasing prevalence of obesity and
aging in developed countries. TKR is clearly effective in reducing pain
and improving function. The outcome of revision surgery is less and even
more costly. Postponing a ﬁrst prosthesis and maintaining quality of life
is at present the major goal in treatment of end stage OA.
Speciﬁc indications for TKR surgery are not clearly deﬁned or evidence
based. Generally accepted indications are pain and restrictions in
performance in spite of the use of (non-)pharmacological interventions.
However, substantial variations in referral behaviour between health
professionals exist. Experts in the ﬁeld believe that in many patients with
severe OA conservative treatment options are not optimally prescribed.
It seems plausible that TKR surgery can be postponed or even prevented.
The aim of this explorative study is to obtain insight in characteristics
and previous pharmacological management of patients with end-stage
knee OA submitted to TKR surgery, and to explore if patients without
adequate pain medication still beneﬁt from pain medication.
Methods: 172 successive patients at the Sint Franciscus Gasthuis,
Rotterdam, referred for TKR were evaluated. Patients not using adequate
analgesics, deﬁned by no or occasional paracetamol (PCM), were
randomized to an adequate dose of an NSAID (celecoxib; 2dd200mg
daily or naproxen; 3dd250mg) or no medication for 6 weeks prior to
surgery.
Patient characteristics, severity of symptoms (WOMAC pain, stiffness and
physical function), medication use in past year and radiological features
(K&L and Altman score) were collected. To calculate the percentage
responders, modiﬁed OMERACT/OARSI responder criteria were used. A
responder was deﬁned as an improvement of ≥50% in function or pain, or
an improvement of ≥20% in pain and function. The study was conducted
according to the declaration of Helsinki and received ethics approval of
the hospital.
Results: In the year prior to referral for TKR 26% (n =44) of patients used
daily NSAIDs, another 27% (n =47) used daily PCM, or occasional NSAID,
and nearly half (47%; n =81) of patients used an occasional PCM or no
medication at all. No signiﬁcant differences in baseline characteristics or
radiographic features were found between these three groups.
Of the 81 patients not using adequate analgesics, 46 patients were
randomized to NSAID treatment and 35 were randomized to no
treatment. Patients without prior adequate pain medication treated for
6 weeks with an NSAID improved on average statistically signiﬁcant in
pain and stiffness (−5.7 [−10.9; −0.5] and −9.6 [−16.4; −2.8], resp. both
p < 0.05). 27% of the patients could be classiﬁed as an actual responder.
